Astria Therapeutics (ATXS) Revenue: 2014-2018
Historic Revenue for Astria Therapeutics (ATXS) over the last 5 years, with Dec 2018 value amounting to -$100,000.
- Astria Therapeutics' Revenue fell 104.00% to -$10,000 in Q3 2018 from the same period last year, while for Sep 2018 it was $150,000, marking a year-over-year change of. This contributed to the annual value of -$100,000 for FY2018, which is 120.00% down from last year.
- According to the latest figures from FY2018, Astria Therapeutics' Revenue is -$100,000, which was down 120.00% from $500,000 recorded in FY2017.
- Over the past 5 years, Astria Therapeutics' Revenue peaked at $500,000 during FY2017, and registered a low of -$978,000 during FY2015.
- Its 3-year average for Revenue is -$145,667, with a median of -$100,000 in 2018.
- As far as peak fluctuations go, Astria Therapeutics' Revenue tumbled by 374.76% in 2015, and later spiked by 159.74% in 2017.
- Yearly analysis of 5 years shows Astria Therapeutics' Revenue stood at -$206,000 in 2014, then tumbled by 374.76% to -$978,000 in 2015, then grew by 14.42% to -$837,000 in 2016, then surged by 159.74% to $500,000 in 2017, then tumbled by 120.00% to -$100,000 in 2018.